The Justice Department continues to aggressively pursue False Claims Act cases. In 2019, DOJ recovered over $3 billion from healthcare, defense and financial companies. The heath care sector -- pharmaceutical, medical device, hospitals and healthcare providers -- continues to be the primary focus of False Claims Act cases. At the same time, qui tam relators initiate a significant percentage of False Claims Act cases.
In this episode, Michael Volkov reviews DOJ's False Claims Act enforcement in 2019 and significant trends.
